Your browser doesn't support javascript.
loading
Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, Gabon.
Alabi, Ayodele; Musangomunei, Fungai P; Lotola-Mougeni, Fabrice; Bie-Ondo, Juste C; Murphy, Kristin; Essone, Paulin N; Kabwende, Anita L; Mahmoudou, Saidou; Macé, Aurélien; Harris, Victoria; Ramharter, Michael; Grobusch, Martin P; Yazdanbakhsh, Maria; Fernandez-Carballo, B Leticia; Escadafal, Camille; Kremsner, Peter G; Dittrich, Sabine; Agnandji, Selidji T.
Afiliação
  • Alabi A; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Musangomunei FP; Institut für Tropenmedizin, Universitätsklinikum Tübingen and German Centre for Infectious Diseases Research (DZIF), Tübingen, Germany.
  • Lotola-Mougeni F; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, The Netherlands.
  • Bie-Ondo JC; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Murphy K; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Essone PN; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Kabwende AL; London School of Hygiene and Tropical Medicine, London, UK.
  • Mahmoudou S; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Macé A; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Harris V; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
  • Ramharter M; FIND, Geneva, Switzerland.
  • Grobusch MP; FIND, Geneva, Switzerland.
  • Yazdanbakhsh M; Department of Tropical Medicine, Department of Internal Medicine I, Bernhard Nocht Institute for Tropical Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Fernandez-Carballo BL; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam Public Health, Amsterdam University Medical Centres, location Amsterdam, Amsterdam Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands.
  • Escadafal C; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, The Netherlands.
  • Kremsner PG; FIND, Geneva, Switzerland.
  • Dittrich S; FIND, Geneva, Switzerland.
  • Agnandji ST; Biomedicine and Social Sciences research group, Department of Biologicals and Therapeutics, Centre de Recherches Médicales de Lambaréné, CERMEL, BP 242, Lambaréné, Gabon.
Infection ; 2024 Aug 23.
Article em En | MEDLINE | ID: mdl-39177882
ABSTRACT

PURPOSE:

The consequent use of malaria rapid diagnostic tests (RDTs) preceding a treatment decision has improved the global management of malaria. A combination RDT, including an inflammation marker to potentially guide antibiotic prescription, could improve the management of acute febrile illness (AFI).

METHODS:

We performed a prospective, cross-sectional study in Gabon evaluating the STANDARD Malaria/CRP DUO (S-DUO) RDT. Participants aged 2 to 17 years with fever at presentation and/or a history of fever < 7 days were enrolled. Expert microscopy, SD Bioline Malaria Ag P.f/Pan test for malaria detection, and NycoCard CRP device for CRP were used as comparators. AFI cases were classified on a spectrum encompassing bacterial vs. non-bacterial infection.

RESULTS:

415 participants with AFI were enrolled. S-DUO RDT sensitivity and specificity for malaria detection vs. microscopy were 99·1% (95·2-100%) and 72·7% (64·3-80·1%); and for CRP detection (20 mg/L and above) 86·9% (80-92%) and 87% (79·2-92·7%), respectively. The difference in CRP levels between bacterial infection (mean = 41·2 mg/L) and other causes of fever, measured from our study population using the Nycocard device, was statistically significant (p < 0·01); CRP precision-recall AUC to distinguish bacterial infection class vs. non-bacterial classifications was 0·79.

CONCLUSION:

S-DUO RDT is suitable for malaria detection in moderate-to-high malaria transmission settings such as in Lambaréné; however, a CRP band detection limit > 40 mg/L is more adequate for indication of antibiotic prescription for AFI cases in Gabon.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infection Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Gabão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infection Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Gabão